Prevalence of hepatitis B and C in urologic surgery patients and urologists
British Journal of Urology, cilt.80, sa.SUPPL. 2, ss.104, 1997 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 80 Sayı: SUPPL. 2
- Basım Tarihi: 1997
- Dergi Adı: British Journal of Urology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.104
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Hepatitis is a crucial problem when an antigenemia seropositive patient undergoes a surgical procedure. The prevalence of hepatitis in urologic surgery patients and urologists is poorly described. The purpose of this study is to evaluate the prevalence of hepatitis B virus(HBV)and hepatitis C virus (HCV) infections and the related risk factors among the urologic surgery patients and the urologists. This cross-sectional, prospective study included 300 consecutive urologie surgery patients and 24 urologists working in our department. The patients and urologists with positive serology for any of the hepatitis viruses were questioned for risk factors including pervious transfusions, surgery, endoscopy. intravenous drug abuse and homosexuality. They were also controlled for serum aminotransferase activities. Positive serology for HBV and HCV was found in 47.4% of the patients and the rate of the patients with antigenemia , the major risk group for the urology team, was 9.9%. Of the 24 urologists working in our department, 3 were antibody to HCV (anti-HCV) positive and 2 were hepatitis B surface antigen (HBsAg) positive. The presence of a risk factor among patients with HBsAg was found in 78.9% and in 100% of that with anti-HCV. This study indicates a high prevalence of HBV and HCV seropositivity in urology patients. In urology wards, the risk of hepatitis transmission i.s estimated to be appreciably high because of the renal transplantation procedure and frequent use of blood and blood-contaminated solutions for transurethral resections or catheter irrigations. Vaccination with HBV vaccine and application of use of universal precautions during daily practice seern to be the only, bui most effective means of protection against bloodborne infections.